First Detection of Mycobacterium tuberculosis Clinical Isolates Harboring I491F Borderline Resistance rpoB Mutation in Myanmar.

Saved in:
Bibliographic Details
Title: First Detection of Mycobacterium tuberculosis Clinical Isolates Harboring I491F Borderline Resistance rpoB Mutation in Myanmar.
Authors: Mon AS; Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar., Ei PW; Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar., Htwe MM; Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar., Nyunt MH; Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar., Win SM; Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar., Nyunt WW; National TB Reference Laboratory, Aung San, Yangon, Myanmar., Myint Z; National Tuberculosis Program (Yangon Branch), Department of Public Health, Yangon, Myanmar., Aung WW; Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Dec 20; Vol. 66 (12), pp. e0092522. Date of Electronic Publication: 2022 Nov 07.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.00925-22